Insider Selling: Intuitive Surgical (NASDAQ:ISRG) SVP Sells $109,936.20 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Patricia Wadors sold 220 shares of the company’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Intuitive Surgical Price Performance

ISRG opened at $503.51 on Monday. The company has a market capitalization of $178.81 billion, a PE ratio of 63.82, a price-to-earnings-growth ratio of 3.88 and a beta of 1.66. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The business has a 50-day moving average of $529.83 and a 200-day moving average of $511.92.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.21 earnings per share. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. UBS Group set a $570.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Tuesday, February 24th. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $714.00 price target on shares of Intuitive Surgical in a research report on Friday, January 9th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, BTIG Research reissued a “buy” rating and set a $616.00 price objective on shares of Intuitive Surgical in a report on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $615.86.

Hedge Funds Weigh In On Intuitive Surgical

Several large investors have recently made changes to their positions in the business. Newbridge Financial Services Group Inc. raised its holdings in Intuitive Surgical by 300.0% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the last quarter. Holos Integrated Wealth LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Tobam increased its position in shares of Intuitive Surgical by 666.7% during the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $27,000. Finally, Greykasell Wealth Strategies Inc. purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $27,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.